FDA Inspection 1063922 — Baylor University Medical Center Transfusion Services
The FDA completed an inspection of Baylor University Medical Center Transfusion Services on August 23, 2018 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 23, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)